en · de · es
selank-notes.peptides3081.com › Wiki › Identity And Structural Background — Explained

Identity And Structural Background — Explained

By Editorial Desk · published 2026-04-17 · last reviewed 2026-05-13 · Wiki

Heptapeptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Last reviewed on 2026-05-13. Where a claim depends on a specific study, the study is described rather than over-claimed.

Identity and Structural Background

Naming for this compound is not fully standardised in English sources. The spelling Selanc appears in some transliterations, and catalogue entries may instead list the peptide sequence itself as the identifier. Reference material sometimes groups it with other short synthetic peptides studied for behavioural effects, which can create confusion when citations are compared. Distinguishing the exact sequence from related tuftsin analogues is therefore a practical first step when reviewing any dataset or specification sheet.

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, frequently abbreviated as TKPRPGP. It was designed as a structural analogue of tuftsin, a naturally occurring tetrapeptide released by enzymatic cleavage of the immunoglobulin heavy chain. The two additional proline residues at the C-terminal end extend the parent chain and change how the molecule behaves in solution. The free peptide has a calculated molecular mass of approximately 751.9 g/mol and is generally supplied as a lyophilised white to off-white powder.

Stability, Handling, and Analytical Control

Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres is the standard purity method. Mass spectrometry, typically electrospray ionisation, confirms identity through the expected mass-to-charge pattern. Amino acid analysis can verify composition independently. Chiral purity requires separate techniques such as derivatisation followed by chromatographic separation, and such data are rarely reported for research-grade material.

Quantification in biological matrices relies on liquid chromatography coupled to tandem mass spectrometry with stable-isotope internal standards. Low plasma concentrations and adsorption to container surfaces both complicate measurement. Solid-phase extraction is often needed to reduce matrix interference before injection. Reported limits of quantification differ widely between laboratories, which makes direct comparison of pharmacokinetic results difficult and limits meta-analysis.

Selank at a glance

PropertyValueNotes
Chemical classSynthetic heptapeptideTuftsin analogue
SequenceThr-Lys-Pro-Arg-Pro-Gly-ProSingle-letter form: TKPRPGP
Molecular formulaC33H57N11O9Calculated for the free peptide
Molecular weightAbout 751.9 g/molDerived from the sequence
AppearanceWhite to off-white powderTypical lyophilised form

Mechanism and Evidence Status

Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.

Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.

Proposed mechanisms centre on the GABAergic system. Animal and tissue studies report changes in GABA-A receptor expression and reduced activity of GABA transaminase, the enzyme that degrades GABA. Effects on monoamine turnover, including serotonin and dopamine pathways, are also described, and a separate line of work links the peptide to increased expression of brain-derived neurotrophic factor in hippocampal tissue. Most of these findings come from rodent models and cell preparations. How the individual observations combine into a single coherent mode of action is not settled.

Related pages on this site

Analytical Methods And Storage Stability

Characterization of Selank in laboratory settings relies on standard peptide analytical techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and degradation products, while mass spectrometry confirms molecular identity through accurate mass measurement. Amino acid analysis and peptide sequencing verify the primary structure when reference material is unavailable. Because Selank is a short chain, fragmentation-based analysis produces a diagnostic ion pattern that supports confident identification.

Peptide stability depends strongly on temperature, moisture, and pH. Lyophilized Selank is generally most stable when stored cold and dry, with freezer temperatures commonly used for long-term storage. In solution, the compound is susceptible to hydrolysis and to microbial growth if it is not handled aseptically. The C-terminal proline-rich extension appears to slow enzymatic cleavage relative to tuftsin, though quantitative degradation rates vary with the matrix and the conditions tested. Published stability data specific to Selank remain sparse.

Peptide Identity and Structure

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter notation. Its structure consists of the immunomodulatory tetrapeptide tuftsin, Thr-Lys-Pro-Arg, extended at the carboxyl terminus by a Pro-Gly-Pro segment. The molecular formula is commonly given as C33H57N11O9, corresponding to a monoisotopic mass near 751.4 Da and an average molecular mass near 751.9 Da. All seven residues are proteinogenic amino acids, and the molecule carries no modified side chains or non-natural linkages.

The compound was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences during the 1980s and 1990s. The stated design goal was to retain the immunomodulatory and central nervous system activity attributed to tuftsin while improving resistance to enzymatic breakdown. Adding a proline-rich tail to the short parent peptide was a deliberate strategy, because proline residues restrict the conformations available to many peptidases. The same laboratory produced Semax, an ACTH fragment analog, and both compounds were developed in parallel as short, enzymatically stabilized peptides intended for intranasal use.

Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.

Administration, Testing and Availability

Published work on this peptide almost always uses intranasal delivery, with drops or a spray applied to the nasal mucosa. Some animal experiments have used subcutaneous or intraperitoneal injection, and a smaller number have compared routes directly. Oral administration is not a focus of the literature, because short peptides of this size are broken down by digestive enzymes and cross intestinal barriers poorly. How much of an intranasal dose reaches the bloodstream intact in humans remains an open question.

Animal studies have examined behaviour in tests of anxiety, memory retention and stress response, and several report changes in neurotrophic or neurotransmitter-related markers. The human evidence base is much smaller, consisting mainly of short trials conducted in Russia with limited reporting in English-language journals. Sample sizes are modest and outcome measures vary between studies, so the findings are best described as preliminary. Independent replication under modern trial standards has not been widely reported.

Supporting material

While attending undergraduate school in Rochester, New York, in 1839, classmates Clarke and Morton apparently participated in ether frolics with some regularity. In January 1842, by now a medical student at Berkshire Medical College, Clarke administered ether to a Miss Hobbie, while Elijah Pope performed a dental extraction. In so doing, he became the first to administer an inhaled anesthetic to facilitate the performance of a surgical procedure. Clarke apparently thought little of his accomplishment, and chose neither to publish nor to pursue this technique any further. Indeed, this event is not even mentioned in Clarke's biography. Crawford W. Long was a physician and pharmacist practicing in Jefferson, Georgia in the mid-19th century. During his time as a student at the University of Pennsylvania School of Medicine in the late 1830s, he had observed and probably participated in the ether frolics that had become popular at that time. At these gatherings, Long observed that some participants experienced bumps and bruises, but afterward had no recall of what had happened. He postulated that diethyl ether produced pharmacologic effects similar to those of nitrous oxide. On 30 March 1842, he administered diethyl ether by inhalation to a man named James Venable, in order to remove a tumor from the man's neck. Long later removed a second tumor from Venable, again under ether anesthesia. He went on to employ ether as a general anesthetic for limb amputations and childbirth.

Bloch's was a philosophy that could hold its head high before the most advanced literature; a philosophy that was not calibrated to the abominable resignation of methodology ... I took this motif so much as my own that I do not believe I have ever written anything without reference to it, either implicit or explicit.Adorno's intellectual non-conformism was also shaped by the repugnance he felt towards the nationalism that swept through the Reich during the First World War. Along with future collaborators Walter Benjamin, Max Horkheimer, and Ernst Bloch, Adorno was profoundly disillusioned by the ease with which Germany's intellectual and spiritual leaders—among them Max Weber, Max Scheler and Georg Simmel, as well as his friend Siegfried Kracauer—came out in support of the war. The younger generation's distrust for traditional knowledge arose from how this tradition had discredited itself. Over time, Oscar Wiesengrund's firm established close professional and personal ties with the factory of Karplus & Herzberger in Berlin. The eldest daughter of the Karplus family, Margarete, or Gretel, moved into the intellectual circles of Berlin, where she became acquainted with Benjamin, Bertolt Brecht, and Bloch, each of whom Adorno would become familiar with during the mid-1920s. After fourteen years, Gretel Karplus and Adorno were married in 1937.

=== MeSH D12.644.548 – peptide hormones === MeSH D12.644.548.009 – activins MeSH D12.644.548.009.500 – inhibin-beta subunits MeSH D12.644.548.014 – adiponectin MeSH D12.644.548.020 – atrial natriuretic factor MeSH D12.644.548.100 – bombesin MeSH D12.644.548.150 – calcitonin MeSH D12.644.548.200 – corticotropin-releasing hormone MeSH D12.644.548.275 – gastric inhibitory polypeptide MeSH D12.644.548.280 – gastrins MeSH D12.644.548.343 – glucagon precursors MeSH D12.644.548.343.249 – enteroglucagons MeSH D12.644.548.343.249.500 – glucagon-like peptide 1 MeSH D12.644.548.343.500 – glucagon MeSH D12.644.548.387 – inhibins MeSH D12.644.548.387.500 – inhibin-beta subunits MeSH D12.644.548.393 – insulin MeSH D12.644.548.393.408 – insulin, isophane MeSH D12.644.548.393.532 – insulin, long-acting MeSH D12.644.548.393.788 – proinsulin MeSH D12.644.548.393.788.250 – c-peptide MeSH D12.644.548.400 – leptin MeSH D12.644.548.500 – motilin MeSH D12.644.548.560 – msh release-inhibiting hormone MeSH D12.644.548.580 – msh-releasing hormone MeSH D12.644.548.585 – natriuretic peptide, c-type MeSH D12.644.548.587 – pancreatic polypeptide MeSH D12.644.548.588 – parathyroid hormone-related protein MeSH D12.644.548.590 – parathyroid hormone MeSH D12.644.548.590.850 – teriparatide MeSH D12.644.548.592 – peptide phi MeSH D12.644.548.595 – peptide yy MeSH D12.644.548.600 – pituitary hormone release inhibiting hormones MeSH D12.644.548.620 – pituitary hormone-releasing hormones MeSH D12.644.548.691 – pituitary hormones MeSH D12.644.548.691.525 – pituitary hormones, anterior MeSH D12.644.548.691.525.343 – gonadotropins, pituitary MeSH D12.644.548.691.525.343.288 – follicle stimulating hormone MeSH D12.644.548.691.525.343.288.500 – follicle stimulating hormone, beta subunit MeSH D12.644.548.691.525.343.288.750 – glycoprotein hormones, alpha subunit MeSH D12.644.548.691.525.343.463 – luteinizing hormone MeSH D12.644.548.691.525.343.463.249 – glycoprotein hormones, alpha subunit MeSH D12.644.548.691.525.343.463.500 – luteinizing hormone, beta subunit MeSH D12.644.548.691.525.343.583 – menotropins MeSH D12.644.548.691.525.343.583.500 – urofollitropin MeSH D12.644.548.691.525.425 – growth hormone MeSH D12.644.548.691.525.425.875 – human growth hormone MeSH D12.644.548.691.525.525 – prolactin MeSH D12.644.548.691.525.690 – pro-opiomelanocortin MeSH D12.644.548.691.525.690.130 – corticotropin MeSH D12.644.548.691.525.690.130.050 – alpha-msh MeSH D12.644.548.691.525.690.130.200 – cosyntropin MeSH D12.644.548.691.525.690.480 – lipotropin MeSH D12.644.548.691.525.690.583 – melanocyte-stimulating hormones MeSH D12.644.548.691.525.690.583.050 – alpha-msh MeSH D12.644.548.691.525.690.583.075 – beta-msh MeSH D12.644.548.691.525.690.583.115 – gamma-msh MeSH D12.644.548.691.525.883 – thyrotropin MeSH D12.644.548.691.525.883.249 – glycoprotein hormones, alpha subunit MeSH D12.644.548.691.525.883.500 – thyrotropin, beta subunit MeSH D12.644.548.691.692 – pituitary hormones, posterior MeSH D12.644.548.691.692.433 – oxytocin MeSH D12.644.548.691.692.781 – vasopressins MeSH D12.644.548.691.692.781.100 – argipressin MeSH D12.644.548.691.692.781.100.250 – deamino arginine vasopressin MeSH D12.644.548.691.692.781.400 – lypressin MeSH D12.644.548.691.692.781.400.350 – felypressin MeSH D12.644.548.691.692.781.700 – ornipressin MeSH D12.644.548.691.692.881 – vasotocin MeSH D12.644.548.726 – placental hormones MeSH D12.644.548.726.367 – chorionic gonadotropin MeSH D12.644.548.726.367.125 – chorionic gonadotropin, beta subunit, human MeSH D12.644.548.726.367.562 – glycoprotein hormones, alpha subunit MeSH D12.644.548.726.451 – gonadotropins, equine MeSH D12.644.548.726.692 – placental lactogen MeSH D12.644.548.762 – relaxin MeSH D12.644.548.786 – resistin MeSH D12.644.548.810 – secretin MeSH D12.644.548.857 – somatostatin MeSH D12.644.548.869 – thymosin MeSH D12.644.548.905 – urotensins MeSH D12.644.548.952 – vasoactive intestinal peptide

=== Pharmacokinetics === Ivermectin can be given by mouth, topically, or via injection. Oral doses are absorbed into systemic circulation; the alcoholic solution form is more orally available than tablet and capsule forms. Ivermectin is widely distributed in the body. Ivermectin does not readily cross the blood-brain barrier of mammals due to the presence of P-glycoprotein (the MDR1 gene mutation affects the function of this protein). Crossing may still become significant if ivermectin is given at high doses, in which case brain levels peak 2–5 hours after administration. In contrast to mammals, ivermectin can cross the blood-brain barrier in tortoises, often with fatal consequences. Ivermectin is metabolized into eight different products by human CYP3A4, two of which (M1, M2) remain toxic to mosquitos. M1 and M2 also have longer elimination half-lives of about 55 hours. CYP3A5 produces a ninth metabolite.

Out Cold is a 2001 American comedy film directed by the music video sibling directing team The Malloys (in their theatrical film directorial debut). Starring Jason London, Willie Garson and Lee Majors, the film is about a group of snowboarders in Alaska. It presents itself as a parody of 1990s "ski school" films and makes a number of references to the film Casablanca.

Sources: en.wikipedia.org

Notes from published material

== Documentaries == To Mars by A-Bomb: The Secret History of Project Orion The Oakes Atomic Dream 2001: The Science of Futures Past Cool It Nuclear Dynamite Gaia Symphony III The Starship and the Canoe The Day After Trinity The Untold History of the United States The Uncertainty Has Settled A Glorious Accident Freeman Dyson: Space Dreamer

=== Image production === Images are constructed by plotting ion intensity versus relative position of the data from the sample. Spatial resolution highly impacts the molecular information gained from analysis.

Hong Kong is situated on China's southern coast, 60 km (37 mi) east of Macau and on the eastern side of the Pearl River estuary. The territory is surrounded by the South China Sea on all sides except the north, where it neighbors the Guangdong city of Shenzhen along the Sham Chun River. Its standard area is approximately 1,110 km2 (430 sq mi), though this figure reaches approximately 2,750 km2 (1,060 sq mi)2 when the open maritime area under its jurisdiction (rather than of mainland China) is included. The territory consists of Hong Kong Island, the Kowloon Peninsula, the New Territories, Lantau Island, and over 200 other islands. Of the standard area, 1,073 km2 (414 sq mi) is land and 35 km2 (14 sq mi) is inland water, such as reservoirs, rivers, and ponds. The territory's highest point is Tai Mo Shan, reaching 957 metres (3,140 ft) above sea level. Urban development is primarily concentrated on the Kowloon Peninsula, Hong Kong Island, and within various new towns throughout the New Territories. Much of this is built on reclaimed land; 70 km2 (27 sq mi) (representing 6% of the total land or about 25% of the territory's developed space) has been reclaimed from the sea.

=== Religion === Bukele's religious beliefs were controversial during his 2019 presidential campaign, with rumors that he was a Christian, a Muslim, or an atheist. The controversy began when pictures from 2011 of Bukele praying at a mosque with his father and brothers spread on social media. Bukele dismissed the controversy as an attempt by the political right to exploit Islamophobia in the predominantly Catholic country. Although Bukele does not identify with any religion, he has stated that he believes in God and Jesus. In a 2015 interview, Bukele said: "I am not a person who believes much in the liturgy of religions. However, I believe in God, in Jesus Christ. I believe in his word, I believe in his word revealed in the Holy Bible. And I know that God does not reject anyone because of their origins". Before that year, some Salvadorans believed that he was a Muslim. Bukele has referred to Bible verses, God, and Saint Óscar Romero — the archbishop of San Salvador who was assassinated in 1980 — in some of his speeches, and has called himself an "instrument of God" ("instrumento de Dios"). He met with Pope Francis in April 2015, saying that the pope told him that Rutilio Grande — a Jesuit priest who was assassinated in 1977 — would soon be beatified.

Sources: en.wikipedia.org

Background from the literature

δDs of fatty acids in living organisms, are typically −73‰ to −237‰. The δDs of individual fatty acids vary widely between cultures (−362‰ to +331‰), but typically by less than around 30‰ between different fatty acids from the same species. The differences in δD for the compounds within the same lipid class is generally less than 50‰, whereas the difference falls in the range of 50‰–150‰ for the compounds in different lipid classes. δDs for typical lipid groups are determined using the following equation:

After its victory in the October 1982 elections, the PSOE remained in power for almost fourteen years. It confirmed its absolute majority in the following two elections (1986 and 1989) and from 1993, although it lost it, it remained the most voted party and was able to continue governing thanks to the support of other groups. During this extended period, the consolidation of the Spanish democracy occurred, and Spain became a society fully comparable to that of its European neighbors.

Overall, the available evidence suggests that laser-based techniques are a minimally invasive treatment option for pilonidal disease with favorable short-term outcomes, while long-term outcomes remain to be further evaluated, necessitating long-term studies to assess its effectiveness as a first-line treatment.

Sources: en.wikipedia.org

Frequently asked questions

What is the peptide sequence of Selank?

The sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, commonly written as TKPRPGP. It shares the first four residues with tuftsin and carries three prolines in the chain. The proline-rich tail is the main structural feature that separates it from the parent tetrapeptide.

How is it related to tuftsin?

Selank is a synthetic analogue built on the tuftsin tetrapeptide Thr-Lys-Pro-Arg. Extra proline residues were added to the C-terminus during design work. That modification is intended to make the peptide less vulnerable to rapid enzymatic degradation.

Why do different sources use different names?

Transliteration from Russian produces variant spellings such as Selanc. Many suppliers avoid the trade-style name entirely and list the peptide sequence. Comparing sequences rather than names is the reliable way to confirm two entries describe the same molecule.

How should the powder be stored?

Dry powder is best kept sealed, protected from light, and held at minus 20 degrees Celsius or below. Desiccant packaging helps limit moisture uptake because the material is hygroscopic. A sealed vial should be allowed to equilibrate to room temperature before opening to reduce condensation.

Network